Navigation Links
Ben-Gurion U. and Fox Chase Cancer Center awarded NIH measles grant
Date:4/18/2013

PHILADELPHIA April 18, 2013 American Associates, Ben-Gurion University of the Negev (AABGU) announces that Ben-Gurion University of the Negev (BGU) and Fox Chase Cancer Center (FCCC) in Philadelphia have received a two-year National Institutes of Health (NIH) research grant to observe "the role of host encoded microRNAs in the maintenance of the measles virus persistent state."

Many viruses are known to persist in their target cells and establish chronic infection, long after resolution of their acute phase. A thorough understanding of this interplay between viruses and their host may offer insight into the mechanistic basis of human infectious diseases.

This research collaboration is part of an ongoing agreement between BGU and FCCC to support and facilitate scientific and clinical exchanges, as well as to encourage collaborations and joint research between scientists and physicians. Fox Chase and Ben-Gurion formalized their relationship in 2008, but it actually began in 2003 as a partnership spearheaded by AABGU's National Vice President Alton I. Sutnick.

Sutnick, founder of the Health Sciences and Academic Affiliations Committee of AABGU's Mid-Atlantic Region, is a physician and former dean of the Medical College of Pennsylvania (now the Drexel University School of Medicine). Through this partnership, he sought to explore the genetic risks of cancer and incorporate these factors into clinical practice across cultural settings.

"Thanks to Dr. Sutnick and AABGU's Philadelphia chapter, BGU has a longstanding research partnership with Fox Chase that has greatly contributed to medical science," explains Doron Krakow, AABGU executive vice president. "It is a great accomplishment to receive this NIH grant and we look forward to their findings."


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Sleep deprivation may reduce risk of PTSD according to Ben-Gurion U. researchers
3. Ben-Gurion University of the Negev receives $450,000 grant to conduct oil and natural gas research
4. Preeclampsia poses a significant long-term health risk according to new research from Ben-Gurion U.
5. Ben-Gurion University team in prestigious DARPA Robotics Challenge to develop disaster response robot
6. Ben-Gurion U. establishes stem cell research fund in honor of inventor Jordan Baruch
7. Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug
8. Obama calls Ben-Gurion U. brain research a great idea
9. Navigating the Patent Minefield of Embryonic Stem Cell Product Development; Free Kindle Fire Tablet and Research Database with Purchase
10. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
11. Embryonic development protein active in cancer growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
(Date:6/30/2015)... Pa. , June 30, 2015 ... the company as CEO to help further develop Genisphere,s ... wealth of partnering experience, having spent much of the ... including Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. ... focus on Technology and Biotech Corporate Finance. He graduated ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... (UK). 8th July 2009 / b3c newswire / - Funxional ... the first Phase I study with FX125L , an ... class named Broad Spectrum Chemokine Inhibitors ( BSCIs ). , ... conducted in the United States. FX125L was well tolerated at ...
... "shut the door" on bacteria that would otherwise infect the ... a team of researchers in Denmark, at the University of ... study, which will appear June 29 in the online journal ... understanding of plants, immune systems and will likely find application ...
... CORVALLIS, Ore. A 700-mile security wall under construction ... alter the movement and "connectivity" of wildlife, biologists say, ... populations of some species. However, technology and alterations ... animals to move more freely between the two countries, ...
Cached Biology News:Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action 2Plant protein 'doorkeepers' block invading microbes, study finds 2Plant protein 'doorkeepers' block invading microbes, study finds 3US-Mexico border wall could threaten wildlife species 2US-Mexico border wall could threaten wildlife species 3US-Mexico border wall could threaten wildlife species 4
(Date:7/30/2015)... ... , ... The 2015 Market Research Report on the Global Propanol Industry ... Propanol market with a focus on the Chinese situation. Major companies included in the ... Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report ...
(Date:7/30/2015)... over 60,000 customers across the globe, ISN improves the efficiency and effectiveness of contractor ... 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than ... Headquartered in Dallas, TX , ISN has additional offices in ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ NS2006L ... operation up to 1500 bar. The sanitary design gauge of the NS2006L is ... , The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
(Date:7/29/2015)... Japan (Q2 2015: +14% CER / 20% of sales) led ... China , as well as solid contributions from Korea, ... / Middle East / Africa ... Germany , Turkey and the ... of sales) grew 11%, excluding U.S. HPV sales, on demand across all customer ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10
... , SAN DIEGO, Sept. 16 ... Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will ... York. , , The live presentation takes ... a.m. Pacific Time (PT). The presentation will be simultaneously webcast ...
... BEIJING, Sept. 16 /PRNewswire-Asia/ ... groups, has announced it will broaden inclusion,criteria for ... will use,stem cells derived from peripheral blood to ... diabetic foot ulcers involves intensive,wound management, risk reduction ...
... ... perform high-throughput insertional mutagenesis screens to identify potential cancer drug targets. , ... Mountain View, CA (PRWEB) September ... RNAi and peptide genetic screens for novel therapeutic target and drug discovery, announced today ...
Cached Biology Technology:Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 2Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 3Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 4CELLECTA, INC. to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research, Inc. 2CELLECTA, INC. to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research, Inc. 3